Embecta (EMBC) EBITDA Margin Growth (3y) (2023 - 2026)
Embecta (EMBC) EBITDA Margin Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 722.00 |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 205.00 |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | -2,360.00 |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 612.00 |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | -368.00 |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | -1,189.00 |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | -1,384.00 |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 799.00 |
| 10 | Embecta | 319.59 Mn | 101.39 Mn | 153.30 Mn | -1.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.00 |
| Mar 31, 2026 | -428.00 |
| Dec 31, 2025 | -32.00 |
| Sep 30, 2025 | 2,249.00 |
| Jun 30, 2025 | -155.00 |
| Mar 31, 2025 | -1,174.00 |
| Dec 31, 2024 | -2,935.00 |
| Sep 30, 2024 | -2,981.00 |
| Jun 30, 2024 | -2,162.00 |
| Mar 31, 2024 | -3,083.00 |
| Dec 31, 2023 | -2,709.00 |